Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke
- PMID: 11175854
- DOI: 10.1038/84675
Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke
Abstract
Vascular endothelial growth factor (VEGF), an angiogenic factor produced in response to ischemic injury, promotes vascular permeability (VP). Evidence is provided that Src kinase regulates VEGF-mediated VP in the brain following stroke and that suppression of Src activity decreases VP thereby minimizing brain injury. Mice lacking pp60c-src are resistant to VEGF-induced VP and show decreased infarct volumes after stroke whereas mice deficient in pp59c-fyn, another Src family member, have normal VEGF-mediated VP and infarct size. Systemic application of a Src-inhibitor given up to six hours following stroke suppressed VP protecting wild-type mice from ischemia-induced brain damage without influencing VEGF expression. This was associated with reduced edema, improved cerebral perfusion and decreased infarct volume 24 hours after injury as measured by magnetic resonance imaging and histological analysis. Thus, Src represents a key intermediate and novel therapeutic target in the pathophysiology of cerebral ischemia where it appears to regulate neuronal damage by influencing VEGF-mediated VP.
Similar articles
-
Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.J Pharmacol Exp Ther. 2009 Dec;331(3):827-35. doi: 10.1124/jpet.109.156562. Epub 2009 Sep 9. J Pharmacol Exp Ther. 2009. PMID: 19741150
-
Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia.J Cereb Blood Flow Metab. 1998 Aug;18(8):887-95. doi: 10.1097/00004647-199808000-00009. J Cereb Blood Flow Metab. 1998. PMID: 9701350
-
Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume.Acta Neurochir (Wien). 2003 Jan;145(1):49-53. doi: 10.1007/s00701-002-1035-1. Acta Neurochir (Wien). 2003. PMID: 12545262
-
Effects of vascular endothelial growth factor in ischemic stroke.J Neurosci Res. 2012 Oct;90(10):1873-82. doi: 10.1002/jnr.23088. Epub 2012 Jun 20. J Neurosci Res. 2012. PMID: 22714747 Review.
-
Vascular endothelial growth factor in cerebral ischemia.J Neurosci Res. 2011 Jul;89(7):969-78. doi: 10.1002/jnr.22628. Epub 2011 Apr 5. J Neurosci Res. 2011. Retraction in: J Neurosci Res. 2012 Jun;90(6):1296. doi: 10.1002/jnr.23043 PMID: 21469168 Retracted. Review.
Cited by
-
Neuroprotective effect of Src kinase in hypoxia-ischemia: A systematic review.Front Neurosci. 2022 Nov 24;16:1049655. doi: 10.3389/fnins.2022.1049655. eCollection 2022. Front Neurosci. 2022. PMID: 36507364 Free PMC article.
-
Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction.J Clin Invest. 2004 Mar;113(6):885-94. doi: 10.1172/JCI20702. J Clin Invest. 2004. PMID: 15067321 Free PMC article.
-
Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy.Nat Commun. 2019 Sep 19;10(1):4262. doi: 10.1038/s41467-019-12282-7. Nat Commun. 2019. PMID: 31537808 Free PMC article.
-
Endothelial cell permeability and adherens junction disruption induced by junín virus infection.Am J Trop Med Hyg. 2014 Jun;90(6):993-1002. doi: 10.4269/ajtmh.13-0382. Epub 2014 Apr 7. Am J Trop Med Hyg. 2014. PMID: 24710609 Free PMC article.
-
A truncated fragment of Src protein kinase generated by calpain-mediated cleavage is a mediator of neuronal death in excitotoxicity.J Biol Chem. 2013 Apr 5;288(14):9696-9709. doi: 10.1074/jbc.M112.419713. Epub 2013 Feb 11. J Biol Chem. 2013. PMID: 23400779 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous